TFAP4 and colorectal carcinoma: These results demonstrate that elevated AP4 expression facilitates the repair of DNA damage by inducing MDC1. By decreasing the amount of DNA damage elevated AP4 expression may therefore contribute to an increased viability and drug resistance of CRC cells.